CureMeAbroad inks MoU to launch first Australian experience centre in Brisbane, eyes 40+ centres globally: Our Bureau, Bengaluru Tuesday, October 13, 2026, 14:50 Hrs [IST] Pune-ba ...
The World Council of Optometry (WCO) and Alcon dry eye initiative’s free digital learning tools for eye care providers are now available in 10 different languages. Both the WCO Alcon Dry Eye Wheel and ...
Eppendorf is expanding its centrifuge portfolio with the launch of the new SpinPro 8 R, a refrigerated, floor -standing high ...
Catalent, Inc., the leading global contract development and manufacturing organization (CDMO) dedicated to helping people live better and healthier lives, and Mantra, a consumer health company ...
UPES concludes World Congress on Health Sciences and Technology (WCHST) 2026 to build future-ready healthcare and research ecosystem: Our Bureau, Mumbai Tuesday, October 13, 2026, ...
Uganda launches phase I clinical study of Bundibugyo virus disease vaccine: Our Bureau, Mumbai Tuesday, October 13, 2026, 17:40 Hrs [IST] The Medical Research Council/Uganda Virus ...
Vedanta’s BALCO Medical Centre expands technology access for early breast cancer detection: Our Bureau, Mumbai Tuesday, October 13, 2026, 15:30 Hrs [IST] To mark Breast Cancer A ...
Tamil Nadu Pharmacy Council is gearing up to host the grand commemoration of World Pharmacists Day 2026 tomorrow at The Tamil Nadu Dr M G R Medical University in Guindy, Chennai. The high-profile ...
AiMeD calls for uniform national framework for healthcare price transparency: Our Bureau, New Delhi Tuesday, October 13, 2026, 15:25 Hrs [IST] The Association of Indian Medical De ...
Remaining milestones: The company expects to submit two additional modules, including the final module containing clinical trial data, towards the end of the second quarter in 2027.
TDB-DST signs agreement with Peptris to accelerate AI-driven drug discovery and development: Our Bureau, Mumbai Tuesday, October 13, 2026, 13:30 Hrs [IST] In a significant step to ...
Bristol Myers Squibb announces positive results from phase 3 ALOFT-IPF trial of admilparant in adults with idiopathic pulmonary fibrosis: Princeton, New Jersey Tuesday, October 13 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results